Public trading strategy
AbbVie drops $10.9B on Apogee — trade the pharma buyout ripple effect
Thesis
When a massive buyout like this happens, it puts a spotlight on the entire sector. Investors will often buy up other smaller biotech firms working on similar treatments, hoping they might become the next takeover targets. By looking at other companies in the immunology space, traders can position themselves ahead of this 'halo effect' buying.
Strategy approach
Build a rule-based strategy that enters long ABBV, and other speculative immunology biotech stocks like IOVA or RVMD, on the 1-day timeframe when the stock's volume is greater than 1.5x its 30-day average volume and the price closes above the previous day's high. Exit on a 5% stop loss or a 15% take profit, with a max hold of 21 days.